Logo image of BG

BUNGE GLOBAL SA (BG) Stock Fundamental Analysis

USA - NYSE:BG - CH1300646267 - Common Stock

79.23 USD
-1.75 (-2.16%)
Last: 10/14/2025, 10:13:01 AM
Fundamental Rating

5

Taking everything into account, BG scores 5 out of 10 in our fundamental rating. BG was compared to 87 industry peers in the Food Products industry. BG has an average financial health and profitability rating. BG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BG was profitable.
BG had a positive operating cash flow in the past year.
In the past 5 years BG has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: BG reported negative operating cash flow in multiple years.
BG Yearly Net Income VS EBIT VS OCF VS FCFBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B -6B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.42%, BG is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
BG has a better Return On Equity (12.66%) than 77.01% of its industry peers.
BG has a Return On Invested Capital of 5.23%. This is comparable to the rest of the industry: BG outperforms 57.47% of its industry peers.
BG had an Average Return On Invested Capital over the past 3 years of 10.77%. This is significantly below the industry average of 28.34%.
The last Return On Invested Capital (5.23%) for BG is well below the 3 year average (10.77%), which needs to be investigated, but indicates that BG had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.42%
ROE 12.66%
ROIC 5.23%
ROA(3y)6.65%
ROA(5y)6.66%
ROE(3y)16.17%
ROE(5y)18.73%
ROIC(3y)10.77%
ROIC(5y)10.22%
BG Yearly ROA, ROE, ROICBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

The Profit Margin of BG (2.71%) is comparable to the rest of the industry.
BG's Profit Margin has declined in the last couple of years.
The Operating Margin of BG (3.24%) is comparable to the rest of the industry.
BG's Operating Margin has improved in the last couple of years.
BG has a Gross Margin of 6.27%. This is amonst the worse of the industry: BG underperforms 80.46% of its industry peers.
In the last couple of years the Gross Margin of BG has grown nicely.
Industry RankSector Rank
OM 3.24%
PM (TTM) 2.71%
GM 6.27%
OM growth 3Y-7.82%
OM growth 5Y6.69%
PM growth 3Y-14.75%
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y3.43%
BG Yearly Profit, Operating, Gross MarginsBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
The number of shares outstanding for BG has been reduced compared to 1 year ago.
The number of shares outstanding for BG has been reduced compared to 5 years ago.
BG has a worse debt/assets ratio than last year.
BG Yearly Shares OutstandingBG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BG Yearly Total Debt VS Total AssetsBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

BG has an Altman-Z score of 3.30. This indicates that BG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.30, BG is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
A Debt/Equity ratio of 0.97 indicates that BG is somewhat dependend on debt financing.
BG's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. BG is outperformed by 71.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 3.3
ROIC/WACC0.7
WACC7.45%
BG Yearly LT Debt VS Equity VS FCFBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

2.3 Liquidity

BG has a Current Ratio of 2.07. This indicates that BG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.07, BG is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that BG should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.29, BG is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.29
BG Yearly Current Assets VS Current LiabilitesBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.21%.
The Earnings Per Share has been growing by 20.28% on average over the past years. This is a very strong growth
Looking at the last year, BG shows a decrease in Revenue. The Revenue has decreased by -8.88% in the last year.
The Revenue has been growing slightly by 5.24% on average over the past years.
EPS 1Y (TTM)-34.21%
EPS 3Y-10.8%
EPS 5Y20.28%
EPS Q2Q%-24.28%
Revenue 1Y (TTM)-8.88%
Revenue growth 3Y-3.53%
Revenue growth 5Y5.24%
Sales Q2Q%-3.56%

3.2 Future

BG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.67% yearly.
Based on estimates for the next years, BG will show a quite strong growth in Revenue. The Revenue will grow by 8.76% on average per year.
EPS Next Y-16.85%
EPS Next 2Y-3.4%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y1.93%
Revenue Next 3Y8.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BG Yearly Revenue VS EstimatesBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
BG Yearly EPS VS EstimatesBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.51, the valuation of BG can be described as reasonable.
78.16% of the companies in the same industry are more expensive than BG, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BG to the average of the S&P500 Index (27.34), we can say BG is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.24, the valuation of BG can be described as reasonable.
Based on the Price/Forward Earnings ratio, BG is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BG to the average of the S&P500 Index (22.86), we can say BG is valued rather cheaply.
Industry RankSector Rank
PE 10.51
Fwd PE 9.24
BG Price Earnings VS Forward Price EarningsBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

74.71% of the companies in the same industry are more expensive than BG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.13
BG Per share dataBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2Y-3.4%
EPS Next 3Y0.67%

6

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 3.45%.
Compared to an average industry Dividend Yield of 5.05, BG pays a bit more dividend than its industry peers.
BG's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.45%

5.2 History

The dividend of BG has a limited annual growth rate of 3.89%.
BG has been paying a dividend for at least 10 years, so it has a reliable track record.
BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.89%
Div Incr Years4
Div Non Decr Years23
BG Yearly Dividends per shareBG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

BG pays out 27.00% of its income as dividend. This is a sustainable payout ratio.
The dividend of BG is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27%
EPS Next 2Y-3.4%
EPS Next 3Y0.67%
BG Yearly Income VS Free CF VS DividendBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B -6B
BG Dividend Payout.BG Dividend Payout, showing the Payout Ratio.BG Dividend Payout.PayoutRetained Earnings

BUNGE GLOBAL SA

NYSE:BG (10/14/2025, 10:13:01 AM)

79.23

-1.75 (-2.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners74.64%
Inst Owner Change0.22%
Ins Owners0.81%
Ins Owner Change4.97%
Market Cap15.85B
Analysts79
Price Target92.75 (17.06%)
Short Float %3.43%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 3.45%
Yearly Dividend2.71
Dividend Growth(5Y)3.89%
DP27%
Div Incr Years4
Div Non Decr Years23
Ex-Date11-17 2025-11-17 (0.7)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.59%
Min EPS beat(2)11.48%
Max EPS beat(2)35.7%
EPS beat(4)3
Avg EPS beat(4)10.71%
Min EPS beat(4)-7.78%
Max EPS beat(4)35.7%
EPS beat(8)6
Avg EPS beat(8)12.16%
EPS beat(12)8
Avg EPS beat(12)13.44%
EPS beat(16)11
Avg EPS beat(16)22.64%
Revenue beat(2)1
Avg Revenue beat(2)-5.3%
Min Revenue beat(2)-13.41%
Max Revenue beat(2)2.81%
Revenue beat(4)1
Avg Revenue beat(4)-3.96%
Min Revenue beat(4)-13.41%
Max Revenue beat(4)2.81%
Revenue beat(8)1
Avg Revenue beat(8)-5.75%
Revenue beat(12)3
Avg Revenue beat(12)-5.52%
Revenue beat(16)5
Avg Revenue beat(16)-3.86%
PT rev (1m)0%
PT rev (3m)1.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.79%
EPS NY rev (1m)0.57%
EPS NY rev (3m)-4.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 10.51
Fwd PE 9.24
P/S 0.31
P/FCF N/A
P/OCF 15.49
P/B 1.46
P/tB 1.57
EV/EBITDA 7.13
EPS(TTM)7.54
EY9.52%
EPS(NY)8.58
Fwd EY10.82%
FCF(TTM)-2.68
FCFYN/A
OCF(TTM)5.11
OCFY6.45%
SpS254.23
BVpS54.4
TBVpS50.52
PEG (NY)N/A
PEG (5Y)0.52
Profitability
Industry RankSector Rank
ROA 4.42%
ROE 12.66%
ROCE 7.94%
ROIC 5.23%
ROICexc 7.68%
ROICexgc 8.06%
OM 3.24%
PM (TTM) 2.71%
GM 6.27%
FCFM N/A
ROA(3y)6.65%
ROA(5y)6.66%
ROE(3y)16.17%
ROE(5y)18.73%
ROIC(3y)10.77%
ROIC(5y)10.22%
ROICexc(3y)12.86%
ROICexc(5y)11.97%
ROICexgc(3y)13.65%
ROICexgc(5y)12.78%
ROCE(3y)14.6%
ROCE(5y)14.18%
ROICexcg growth 3Y-15.42%
ROICexcg growth 5Y5.22%
ROICexc growth 3Y-14.88%
ROICexc growth 5Y6.42%
OM growth 3Y-7.82%
OM growth 5Y6.69%
PM growth 3Y-14.75%
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y3.43%
F-Score4
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 4.97
Cap/Depr 326.15%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 48.07%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 1.29
Altman-Z 3.3
F-Score4
WACC7.45%
ROIC/WACC0.7
Cap/Depr(3y)226.28%
Cap/Depr(5y)171.37%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.21%
EPS 3Y-10.8%
EPS 5Y20.28%
EPS Q2Q%-24.28%
EPS Next Y-16.85%
EPS Next 2Y-3.4%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.88%
Revenue growth 3Y-3.53%
Revenue growth 5Y5.24%
Sales Q2Q%-3.56%
Revenue Next Year-1.55%
Revenue Next 2Y1.93%
Revenue Next 3Y8.76%
Revenue Next 5YN/A
EBIT growth 1Y-26.83%
EBIT growth 3Y-11.07%
EBIT growth 5Y12.28%
EBIT Next Year14.94%
EBIT Next 3Y15.24%
EBIT Next 5YN/A
FCF growth 1Y64.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y265%
OCF growth 3YN/A
OCF growth 5YN/A